Joo Mey
voted
Updated on October 15
Semiconductor company $ASML Holding (ASML.US)$ experienced its largest drop in 26 years on October 15 after reporting only about half the orders that analysts had anticipated from chipmakers, signaling a significant slowdown for this key industry player, according to Bloomberg.
The disappointing results were further exacerbated by the company accidentally releasing its earnings report a day early. This news prompted a wid...
Semiconductor company $ASML Holding (ASML.US)$ experienced its largest drop in 26 years on October 15 after reporting only about half the orders that analysts had anticipated from chipmakers, signaling a significant slowdown for this key industry player, according to Bloomberg.
The disappointing results were further exacerbated by the company accidentally releasing its earnings report a day early. This news prompted a wid...
+2
442
195
$Faraday Future Intelligent Electric Inc. (FFIE.US)$
3 times circuit breaker😶🌫️
3 times circuit breaker😶🌫️
2
1
Joo Mey
reacted to
$Faraday Future Intelligent Electric Inc. (FFIE.US)$
Faraday Future Reports Financial Results for Second Quarter 2024 and Announces Timing for Earnings Call
Positive
Operating expenses decreased to $29.9 million from $49.4 million year-over-year
Loss from operations improved to $50.6 million from $56.0 million year-over-year
Cash used in operating activities reduced to $29.1 million in H1 2024 from $160.7 million in the prior year period
Raised approximately $15.5 million through converti...
Faraday Future Reports Financial Results for Second Quarter 2024 and Announces Timing for Earnings Call
Positive
Operating expenses decreased to $29.9 million from $49.4 million year-over-year
Loss from operations improved to $50.6 million from $56.0 million year-over-year
Cash used in operating activities reduced to $29.1 million in H1 2024 from $160.7 million in the prior year period
Raised approximately $15.5 million through converti...
9
Joo Mey
commented on
$Atara Biotherapeutics (ATRA.US)$
Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update
Atara Biotherapeutics (Nasdaq: ATRA) reported Q2 2024 financial results and operational progress. Key highlights include:
1. Tab-cel® U.S. BLA accepted under Priority Review with PDUFA date of January 15, 2025.
2. ATA3219 studies in Lupus Nephritis and Severe Systemic Lupus Erythematosus to start Q4 2024; initial data expected mid-2025.
3. ATA3...
Atara Biotherapeutics Announces Second Quarter 2024 Financial Results, Operational Progress and Leadership Update
Atara Biotherapeutics (Nasdaq: ATRA) reported Q2 2024 financial results and operational progress. Key highlights include:
1. Tab-cel® U.S. BLA accepted under Priority Review with PDUFA date of January 15, 2025.
2. ATA3219 studies in Lupus Nephritis and Severe Systemic Lupus Erythematosus to start Q4 2024; initial data expected mid-2025.
3. ATA3...
1
5
$Faraday Future Intelligent Electric Inc. (FFIE.US)$
No topic to typing..but im just want to say, Just hodl and silent..
something good will happen this month🚀🚀🚀
#Dump ape was here
No topic to typing..but im just want to say, Just hodl and silent..
something good will happen this month🚀🚀🚀
#Dump ape was here
2
2